Journal
AMERICAN JOURNAL OF THE MEDICAL SCIENCES
Volume 345, Issue 6, Pages 431-436Publisher
ELSEVIER SCIENCE INC
DOI: 10.1097/MAJ.0b013e318294457f
Keywords
Epidemiology; Spondyloarthritis; HLA-B27; Back pain; Ankylosing spondylitis
Categories
Funding
- NIAMS NIH HHS [P01 AR052915, 2P01AR052915-06A1] Funding Source: Medline
Ask authors/readers for more resources
The concept of inflammatory back pain (IBP) evolved in the 1970s, coincident with the discovery of the HLA-B27 association with ankylosing spondylitis (AS), leading to the development of criteria to determine the presence of IBP. The concept of IBP and it relationship with AS and axial spondyloarthritis (AxSpA) has further evolved, and an instrument developed (the Spondylitis Association of America Back Pain Tool), which was further modified and field tested for use in the 2009 to 2010 National Health and Nutrition Examination Survey (NHANES). This has shown the frequency of chronic back pain to have risen to 19.4%, with nearly one third having IBP. The prevalence of AxSpA has been defined at 1.0% to 1.4% and AS at 0.52% to 0.55%. The national prevalence of HLA-B27 in the United States is 6.1%, and intriguing data from NHANES 2009 suggest a decreasing frequency with increasing age. From this arise new questions and a work agenda ahead.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available